CPS Print Publications
CPhA offers 5 print publications.
ON SALE - SAVE 10% Print edition $460.80 (reg. $512) (Prices are in CAD$)
CPS: Drug Information contains thousands of products including monographs for drugs, vaccines, natural health and medical devices. This definitive resource also includes CPhA monographs written by the Canadian Pharmacists Association's editorial staff, based on the best available evidence and reviewed by expert physicians and pharmacists. Clinical tools and directories of drug and healthcare information are also included. Two volume set: A-L and M-Z. Updated annually, it is the only comprehensive print reference for Canadian drug information – and has been for over 55 years.
ON SALE - SAVE 10% Print edition $232.20 (reg. $258) (Prices are in CAD$)
CPS: Therapeutic Choices is the trusted reference for Canada’s health care providers, guiding clinical decision making at the point of care by providing unbiased, evidence-based, practical information on hundreds of medical conditions. Practical, bottom-line, clinical information covering more than 200 common medical conditions is referenced and organized in a concise format by therapeutic condition. More than 70 chapters cover drug therapy during pregnancy and breastfeeding. The content is based on the best available evidence, subject to a rigorous peer review process.
New Content Includes: HIV Prevention, Deprescribing, Constipation in Children, Diverticular Disease, and more.
ON SALE - SAVE 10% Print edition $278.10 (reg. $309) (Prices are in CAD$)
Compendium of Therapeutics for Minor Ailments presents the best-available evidence to help you manage and triage minor ailments, covering the full spectrum of therapy for over 140 conditions. This quick reference provides the tools you need to confidently assess and manage your patients’ minor ailments.
ON SALE - SAVE 10% Print edition $126.90 (reg. $141) (Prices are in CAD$)
Compendium of Products for Minor Ailments offers an unrivalled compilation of non-prescription drugs and devices marketed in Canada to help health care practitioners select treatments for the management of minor ailments. Products are conveniently organized into tables to highlight comparative ingredients and features.
Minor Ailment Bundle
ON SALE - SAVE 10% Print edition $355.50 (reg. $395) (Prices are in CAD$)
Product categories for Compendium of Products for Minor Ailments include: baby care; cough, cold, and allergy; home testing; ostomy; skin care; and vitamins and minerals. Topics in Compendium of Therapeutics for Minor Ailments include the following sections – pathophysiology, assessment and treatment algorithms, drug tables, patient handouts, and suggested resources for patients.
Purchase Compendium of Therapeutics for Minor Ailments and Compendium of Products for Minor Ailments together and save $55!
Pharmacy Management in Canada
ON SALE - SAVE 10% Print edition $136.80 (reg. $152) (Prices are in CAD$)
The Canadian Foundation for Pharmacy is proud to present an all-Canadian textbook, authored and reviewed by experts with years of experience in pharmacy management. It covers from analysis and planning, financial and risk management, to operations, quality control, human resources, marketing and communications, pharmacy services and business plans. It is an excellent educational tool and reference guide for pharmacy students, international pharmacy graduates, practising pharmacists and pharmacy owners and managers.
If you are buying 10 or more copies, contact us for bulk pricing.
Consult our fee policy to ensure you are licensed appropriately.
Each therapeutic topic is written by an expert author and is based on the best available evidence. CPhA employs a rigorous review process to ensure that the information is accurate and unbiased. Content is extensively reviewed and validated by skilled CPhA clinical editors and by external reviewers who are recognized experts (physicians and pharmacists) in their particular clinical area.
CPhA asks authors to disclose any potential conflicts of interest. CPhA does not accept funding from pharmaceutical manufacturers for any content that we develop.